HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Raimund Wagener Selected Research

Skin Abnormalities

1/2014Col6a1 null mice as a model to study skin phenotypes in patients with collagen VI related myopathies: expression of classical and novel collagen VI variants during wound healing.
1/2011Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Raimund Wagener Research Topics

Disease

7Osteoarthritis
08/2013 - 02/2004
5Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
08/2013 - 02/2004
3Fibrosis (Cirrhosis)
10/2015 - 04/2012
3Muscular Diseases (Myopathy)
04/2014 - 01/2011
2Skin Abnormalities
01/2014 - 01/2011
2Cicatrix (Scar)
01/2014 - 01/2011
2Atopic Dermatitis (Atopic Eczema)
01/2011 - 04/2008
1Muscle Weakness
04/2014
1Muscular Dystrophies (Muscular Dystrophy)
02/2014
1Keratosis
01/2014
1Keloid
01/2014
1Wounds and Injuries (Trauma)
01/2014
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
04/2012
1Fetal Diseases (Embryopathy)
09/2011
1Intervertebral Disk Degeneration
03/2011
1Fraser Syndrome
04/2010
1Neoplasms (Cancer)
10/2009
1Dwarfism
07/2007
1Hemorrhage
12/2006
1Pain (Aches)
02/2004
1Chondrosarcoma
09/2003

Drug/Important Bio-Agent (IBA)

9CollagenIBA
04/2014 - 09/2003
7matrilin 3IBA
03/2011 - 02/2004
3Scleroatonic muscular dystrophyIBA
04/2014 - 04/2008
3Bethlem myopathyIBA
04/2014 - 04/2008
2Staphylococcal Protein A (A, Protein)IBA
02/2014 - 03/2011
2Burnett Schwartz Berberian syndromeIBA
01/2014 - 01/2011
2Proteins (Proteins, Gene)IBA
08/2013 - 12/2006
2Epidermal Growth Factor (EGF)IBA
03/2011 - 10/2009
2Extracellular Matrix ProteinsIBA
12/2006 - 09/2003
1LipodermatosclerosisIBA
10/2015
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2014
1PseudoachondroplasiaIBA
08/2013
1Glutamic Acid (Glutamate)FDA Link
09/2011
1Warfarin (Coumadin)FDA LinkGeneric
09/2011
1von Willebrand FactorIBA
03/2011
1Proteoglycans (Proteoglycan)IBA
03/2011
1FurinIBA
04/2010
1type 2 alpha 1 CollagenopathyIBA
03/2010
1LigandsIBA
09/2003